Resolution of platelet-rich thrombi in essential thrombocythemia: mechanisms, risks, and benefits of antiplatelet therapy.
Loscalzo
J
J
D002986:Clinical Trials as Topic; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010976:Platelet Count; D011379:Prognosis; D018570:Risk Assessment; D013922:Thrombocytosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology*; D013923:Thromboembolism / Q000150:complications* / Q000188:drug therapy*; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors